A customizable, scalable electroporation system for GMP-compliant cell therapy manufacturing

Produced by Thermo Fisher Scientific

Featuring programmable, flexible electroporation conditions, the CTS Xenon Electroporation System allows cell therapy developers to optimize a variety of hard-to-transfect cell types and payloads. Users can optimize multiple electroporation conditions simultaneously and identify the best electroporation conditions for unique cell and payload combinations. Once the ideal protocol has been identified, the system can be configured to a clinical manufacturing mode. The system has been specifically designed to enable an easier transition from the bench to the clinic.

Over 1,000 cell and gene therapy candidates are in clinical trials, which means there will likely be demand for pharmaceutical services that outstrip supply. The Gibco CTS Xenon Electroporation System helps researchers overcome manufacturing challenges to bring cell therapies to more patients. Using the modular Xenon System for nonviral gene modification enables time-consuming processes such as cell expansion, to be decoupled from rapid processes, such as gene delivery, improving facility and equipment utilization, and reducing the capital investment required.